{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:15:57Z","timestamp":1778656557918,"version":"3.51.4"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05898-6","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:47:53Z","timestamp":1778644073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Xinyu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cancan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongquan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"5898_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303","journal-title":"Lancet"},{"key":"5898_CR2","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"5898_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"5898_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2023) Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol Mech Dis 18:95\u2013121","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5898_CR5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"5898_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u0131\u0301z","year":"2004","unstructured":"Pais\u00e1n-Ru\u0131\u0301z C et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44:595\u2013600","journal-title":"Neuron"},{"key":"5898_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM et al (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160","journal-title":"Science"},{"key":"5898_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"5898_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259","journal-title":"Science"},{"key":"5898_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00401-019-01993-2","volume":"137","author":"D Hu","year":"2019","unstructured":"Hu D et al (2019) Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol (Berl) 137:939\u2013960","journal-title":"Acta Neuropathol (Berl)"},{"key":"5898_CR11","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"A-L Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier A-L et al (2020) The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci U S A 117:4971\u20134982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5898_CR12","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"SA Tanik","year":"2013","unstructured":"Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR, Lee VMY (2013) Lewy body-like \u03b1-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem 288:15194\u201315210","journal-title":"J Biol Chem"},{"key":"5898_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","volume":"10","author":"GK Ganjam","year":"2019","unstructured":"Ganjam GK et al (2019) Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons. Cell Death Dis 10:865","journal-title":"Cell Death Dis"},{"key":"5898_CR14","doi-asserted-by":"publisher","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"AK Reeve","year":"2015","unstructured":"Reeve AK et al (2015) Aggregated \u03b1-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis 6:e1820\u2013e1820","journal-title":"Cell Death Dis"},{"key":"5898_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","volume":"10","author":"Y Xia","year":"2019","unstructured":"Xia Y et al (2019) Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 10:174","journal-title":"Cell Death Dis"},{"key":"5898_CR16","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H et al (2021) Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 184:5089-5106.e21","journal-title":"Cell"},{"key":"5898_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M et al (2020) Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain 143:1476\u20131497","journal-title":"Brain"},{"key":"5898_CR18","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bov\u00e9 J (2020) CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease. Brain 143:3717\u20133733","journal-title":"Brain"},{"key":"5898_CR19","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K et al (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10:5816","journal-title":"Nat Commun"},{"key":"5898_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"3535","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM (2015) Striatal blood\u2013brain barrier permeability in Parkinson\u2019s disease. J Cereb Blood Flow Metab 3535:747\u2013750","journal-title":"J Cereb Blood Flow Metab"},{"key":"5898_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D et al (2017) T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature 546:656\u2013661","journal-title":"Nature"},{"key":"5898_CR22","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL et al (2016) Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med 213:1759\u20131778","journal-title":"J Exp Med"},{"key":"5898_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey NL et al (2018) Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol (Berl) 135:65\u201383","journal-title":"Acta Neuropathol (Berl)"},{"key":"5898_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-pharmtox-022124-033653","volume":"65","author":"E Menozzi","year":"2025","unstructured":"Menozzi E, Schapira AHV (2025) Prospects for disease slowing in Parkinson disease. Annu Rev Pharmacol Toxicol 65:237\u2013258","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5898_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1741-6612.2012.00632.x","volume":"31","author":"S Aarons","year":"2012","unstructured":"Aarons S, Peisah C, Wijeratne C (2012) Neuropsychiatric effects of Parkinson\u2019s disease treatment. Australas J Ageing 31:198\u2013202","journal-title":"Australas J Ageing"},{"key":"5898_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","volume":"9","author":"J Gao","year":"2024","unstructured":"Gao J et al (2024) Precision drug delivery to the central nervous system using engineered nanoparticles. Nat Rev Mater 9:567\u2013588","journal-title":"Nat Rev Mater"},{"key":"5898_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","volume":"14","author":"G Cheng","year":"2022","unstructured":"Cheng G et al (2022) Anti-Parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials. Nano-Micro Lett 14:105","journal-title":"Nano-Micro Lett"},{"key":"5898_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/1871524919666181126124846","volume":"19","author":"N Mishra","year":"2019","unstructured":"Mishra N, Sharma S, Deshmukh R, Kumar A, Sharma R (2019) Development and characterization of nasal delivery of selegiline hydrochloride loaded nanolipid carriers for the management of Parkinson\u2019s disease. Cent Nerv Syst Agents Med Chem 19:46\u201356","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"5898_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","volume":"34","author":"SB Arya","year":"2024","unstructured":"Arya SB, Collie SP, Parent CA (2024) The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol 34:90\u2013108","journal-title":"Trends Cell Biol"},{"key":"5898_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 19:47","journal-title":"Cell Commun Signal"},{"key":"5898_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01055-0","volume":"31","author":"Y-F Chen","year":"2024","unstructured":"Chen Y-F, Luh F, Ho Y-S, Yen Y (2024) Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. J Biomed Sci 31:67","journal-title":"J Biomed Sci"},{"key":"5898_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41423-025-01323-5","volume":"22","author":"W Wang","year":"2025","unstructured":"Wang W, Qiao S, Kong X, Zhang G, Cai Z (2025) The role of exosomes in immunopathology and potential therapeutic implications. Cell Mol Immunol 22:975\u2013995","journal-title":"Cell Mol Immunol"},{"key":"5898_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00280-9","volume":"6","author":"S Huang","year":"2025","unstructured":"Huang S et al (2025) Exosomes in inflammation and cancer: from bench to bedside applications. Mol Biomed 6:41","journal-title":"Mol Biomed"},{"key":"5898_CR34","volume":"11","author":"T Gong","year":"2024","unstructured":"Gong T, Liu Y-T, Fan J (2024) Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction. Mil Med Res 11:24","journal-title":"Mil Med Res"},{"key":"5898_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nano11061481","volume":"11","author":"A Butreddy","year":"2021","unstructured":"Butreddy A, Kommineni N, Dudhipala N (2021) Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials 11:1481","journal-title":"Nanomaterials"},{"key":"5898_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03521-2","volume":"13","author":"S Sen","year":"2023","unstructured":"Sen S, Xavier J, Kumar N, Ahmad MZ, Ranjan OP (2023) Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech 13:101","journal-title":"3 Biotech"},{"key":"5898_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304","journal-title":"Lancet"},{"key":"5898_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-cellbio-100818-125512","volume":"36","author":"PK Singh","year":"2020","unstructured":"Singh PK, Muqit MMK (2020) Parkinson\u2019s: a disease of aberrant vesicle trafficking. Annu Rev Cell Dev Biol 36:237\u2013264","journal-title":"Annu Rev Cell Dev Biol"},{"key":"5898_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041187","volume":"11","author":"DJ Rademacher","year":"2023","unstructured":"Rademacher DJ (2023) Potential for therapeutic-loaded exosomes to ameliorate the pathogenic effects of \u03b1-synuclein in Parkinson\u2019s disease. Biomedicines 11:1187","journal-title":"Biomedicines"},{"key":"5898_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13287-022-03050-4","volume":"13","author":"RM Heris","year":"2022","unstructured":"Heris RM et al (2022) The potential use of mesenchymal stem cells and their exosomes in Parkinson\u2019s disease treatment. Stem Cell Res Ther 13:371","journal-title":"Stem Cell Res Ther"},{"key":"5898_CR41","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1007\/s12035-025-04788-7","volume":"62","author":"F Almasi","year":"2025","unstructured":"Almasi F et al (2025) Biology, pathology, and targeted therapy of exosomal cargoes in Parkinson\u2019s disease: advances and challenges. Mol Neurobiol 62:8381\u20138399","journal-title":"Mol Neurobiol"},{"key":"5898_CR42","doi-asserted-by":"publisher","first-page":"11054","DOI":"10.3390\/ijms241311054","volume":"24","author":"A He","year":"2023","unstructured":"He A et al (2023) Role of exosomes in the pathogenesis and theranostic of Alzheimer\u2019s disease and Parkinson\u2019s disease. Int J Mol Sci 24:11054","journal-title":"Int J Mol Sci"},{"key":"5898_CR43","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-024-12329-w","volume":"271","author":"H Tao","year":"2024","unstructured":"Tao H, Gao B (2024) Exosomes for neurodegenerative diseases: diagnosis and targeted therapy. J Neurol 271:3050\u20133062","journal-title":"J Neurol"},{"key":"5898_CR44","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M et al (2023) The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): intercellular shuttles and implications in human diseases. Genes Dis 10:1894\u20131907","journal-title":"Genes Dis"},{"key":"5898_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010255","volume":"25","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xiao T, Zhao C, Li G (2023) The regulation of exosome generation and function in physiological and pathological processes. Int J Mol Sci 25:255","journal-title":"Int J Mol Sci"},{"key":"5898_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122639","volume":"9","author":"LC Zanetti-Domingues","year":"2020","unstructured":"Zanetti-Domingues LC, Bonner SE, Iyer RS, Martin-Fernandez ML, Huber V (2020) Cooperation and interplay between EGFR signalling and extracellular vesicle biogenesis in cancer. Cells 9:2639","journal-title":"Cells"},{"key":"5898_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1541-7786.MCR-18-0891","volume":"17","author":"A Gonda","year":"2019","unstructured":"Gonda A, Kabagwira J, Senthil GN, Wall NR (2019) Internalization of exosomes through receptor-mediated endocytosis. Mol Cancer Res 17:337\u2013347","journal-title":"Mol Cancer Res"},{"key":"5898_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41422-020-00418-0","volume":"31","author":"CM Kenific","year":"2021","unstructured":"Kenific CM, Zhang H, Lyden D (2021) An exosome pathway without an ESCRT. Cell Res 31:105\u2013106","journal-title":"Cell Res"},{"key":"5898_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1083\/jcb.201212113","volume":"200","author":"CV Harding","year":"2013","unstructured":"Harding CV, Heuser JE, Stahl PD (2013) Exosomes: looking back three decades and into the future. J Cell Biol 200:367\u2013371","journal-title":"J Cell Biol"},{"key":"5898_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"Q-F Han","year":"2022","unstructured":"Han Q-F et al (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21:207","journal-title":"Mol Cancer"},{"key":"5898_CR51","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41467-021-22126-y","volume":"12","author":"E Bonsergent","year":"2021","unstructured":"Bonsergent E et al (2021) Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat Commun 12:1864","journal-title":"Nat Commun"},{"key":"5898_CR52","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI et al (2024) Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med 56:836\u2013849","journal-title":"Exp Mol Med"},{"key":"5898_CR53","doi-asserted-by":"crossref","unstructured":"Ikezu T et al (2024) Extracellular vesicle-mediated neuron\u2013glia communications in the central nervous system. J Neurosci 44  e1170242024","DOI":"10.1523\/JNEUROSCI.1170-24.2024"},{"key":"5898_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1154576","volume":"11","author":"K Lopez","year":"2023","unstructured":"Lopez K, Lai SWT, Lopez Gonzalez EDJ, D\u00e1vila RG, Shuck SC (2023) Extracellular vesicles: a dive into their role in the tumor microenvironment and cancer progression. Front Cell Dev Biol 11:1154576","journal-title":"Front Cell Dev Biol"},{"key":"5898_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","volume":"287","author":"M Qu","year":"2018","unstructured":"Qu M et al (2018) Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson\u2019s disease. J Controlled Release 287:156\u2013166","journal-title":"J Controlled Release"},{"key":"5898_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3553617","volume":"2022","author":"W Zhang","year":"2022","unstructured":"Zhang W, Liu R, Chen Y, Wang M, Du J (2022) Crosstalk between oxidative stress and exosomes. Oxid Med Cell Longev 2022:3553617","journal-title":"Oxid Med Cell Longev"},{"key":"5898_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00551-3","volume":"29","author":"Z Vahidinia","year":"2024","unstructured":"Vahidinia Z, Azami Tameh A, Barati S, Izadpanah M, Seyed Hosseini E (2024) Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies. Cell Mol Biol Lett 29:30","journal-title":"Cell Mol Biol Lett"},{"key":"5898_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00774-y","volume":"28","author":"P-C Pao","year":"2021","unstructured":"Pao P-C, Tsai L-H (2021) Three decades of Cdk5. J Biomed Sci 28:79","journal-title":"J Biomed Sci"},{"key":"5898_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jare.2023.01.001","volume":"53","author":"T Accogli","year":"2023","unstructured":"Accogli T, Hibos C, Vegran F (2023) Canonical and non-canonical functions of NLRP3. J Adv Res 53:137\u2013151","journal-title":"J Adv Res"},{"key":"5898_CR60","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","volume":"23","author":"Q Li","year":"2021","unstructured":"Li Q, Wang Z, Xing H, Wang Y, Guo Y (2021) Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease. Mol Ther Nucleic Acids 23:1334\u20131344","journal-title":"Mol Ther Nucleic Acids"},{"key":"5898_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ et al (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 207:18\u201330","journal-title":"J Control Release"},{"key":"5898_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"Y-T Sui","year":"2014","unstructured":"Sui Y-T, Bullock KM, Erickson MA, Zhang J, Banks WA (2014) Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 62:197\u2013202","journal-title":"Peptides"},{"key":"5898_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2019.09.008","volume":"67","author":"K Rani","year":"2019","unstructured":"Rani K et al (2019) Neuronal exosomes in saliva of Parkinson\u2019s disease patients: a pilot study. Parkinsonism Relat Disord 67:21\u201323","journal-title":"Parkinsonism Relat Disord"},{"key":"5898_CR64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M et al (2014) Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol (Berl) 128:639\u2013650","journal-title":"Acta Neuropathol (Berl)"},{"key":"5898_CR65","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43587-024-00792-z","volume":"5","author":"L Zhang","year":"2025","unstructured":"Zhang L et al (2025) Modulating mTOR-dependent astrocyte substate transitions to alleviate neurodegeneration. Nat Aging 5:468\u2013485","journal-title":"Nat Aging"},{"key":"5898_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/svn-2024-003509","volume":"10","author":"B Sheng","year":"2025","unstructured":"Sheng B et al (2025) Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage. Stroke Vasc Neurol 10:335\u2013346","journal-title":"Stroke Vasc Neurol"},{"key":"5898_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s12276-024-01388-8","volume":"57","author":"C-J Lee","year":"2025","unstructured":"Lee C-J et al (2025) Exosome-based targeted delivery of NF-\u03baB ameliorates age-related neuroinflammation in the aged mouse brain. Exp Mol Med 57:235\u2013248","journal-title":"Exp Mol Med"},{"key":"5898_CR68","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","volume":"10","author":"Z-H Zhao","year":"2019","unstructured":"Zhao Z-H et al (2019) Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease. Front Aging Neurosci 10:438","journal-title":"Front Aging Neurosci"},{"key":"5898_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114950","volume":"159","author":"MA Alhadad","year":"2025","unstructured":"Alhadad MA, Zaafan MA, El-Tanbouly DM, Elbrairy AI, Zaki HF (2025) Modulating the renin-angiotensin system by eprosartan or xanthenone drives microglial M2 polarization in a rat model of Parkinson\u2019s disease via regulating the interplay between MKP-1\/ miR-155 \/SOCS1 and PP2A signaling network. Int Immunopharmacol 159:114950","journal-title":"Int Immunopharmacol"},{"key":"5898_CR70","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-025-02015-x","volume":"13","author":"A Filippini","year":"2025","unstructured":"Filippini A, Carini G, Barbon A, Gennarelli M, Russo I (2025) Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up \u03b1-synuclein fibrils. Acta Neuropathol Commun 13:98","journal-title":"Acta Neuropathol Commun"},{"key":"5898_CR71","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1042\/BST20180467","volume":"47","author":"S Wang","year":"2019","unstructured":"Wang S, West AB (2019) Caught in the act: LRRK2 in exosomes. Biochem Soc Trans 47:663\u2013670","journal-title":"Biochem Soc Trans"},{"key":"5898_CR72","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","volume":"18","author":"J Alegre-Abarrategui","year":"2009","unstructured":"Alegre-Abarrategui J et al (2009) LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 18:4022\u20134034","journal-title":"Hum Mol Genet"},{"key":"5898_CR73","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41419-023-05964-0","volume":"14","author":"E Kania","year":"2023","unstructured":"Kania E et al (2023) LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a\/Rab10-dependent manner. Cell Death Dis 14:436","journal-title":"Cell Death Dis"},{"key":"5898_CR74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol 23:329","journal-title":"J Nanobiotechnol"},{"key":"5898_CR75","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.23743","author":"L Cheng","year":"2014","unstructured":"Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. https:\/\/doi.org\/10.3402\/jev.v3.23743","journal-title":"J Extracell Vesicles"},{"key":"5898_CR76","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA et al (2020) Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci 21:4407","journal-title":"Int J Mol Sci"},{"key":"5898_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1358-y","volume":"10","author":"P Hong","year":"2019","unstructured":"Hong P, Yang H, Wu Y, Li K, Tang Z (2019) The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: a comprehensive review. Stem Cell Res Ther 10:242","journal-title":"Stem Cell Res Ther"},{"key":"5898_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00665-8","volume":"18","author":"D Jiang","year":"2020","unstructured":"Jiang D et al (2020) Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J Nanobiotechnol 18:105","journal-title":"J Nanobiotechnol"},{"key":"5898_CR79","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.18632\/aging.202466","volume":"13","author":"Z Zhang","year":"2021","unstructured":"Zhang Z et al (2021) Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1\/TRAF6 signaling pathway after ischemic stroke. Aging (Albany NY) 13:3060\u20133079","journal-title":"Aging (Albany NY)"},{"key":"5898_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118403","volume":"260","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Gan Y, Xu G, Hua K, Liu D (2020) Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation. Life Sci 260:118403","journal-title":"Life Sci"},{"key":"5898_CR81","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbi.2019.11.004","volume":"83","author":"Z Yin","year":"2020","unstructured":"Yin Z et al (2020) Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture. Brain Behav Immun 83:270\u2013282","journal-title":"Brain Behav Immun"},{"key":"5898_CR82","doi-asserted-by":"crossref","unstructured":"Li P et al (2022) Increased miR-155 in microglial exosomes following heat stress accelerates neuronal autophagy via their transfer into neurons. Front Cell Neurosci 16:865568","DOI":"10.3389\/fncel.2022.865568"},{"key":"5898_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112326","volume":"135","author":"Z Shi","year":"2024","unstructured":"Shi Z et al (2024) Extracellular vesicles containing miR-181a-5p as a novel therapy for experimental autoimmune encephalomyelitis-induced demyelination. Int Immunopharmacol 135:112326","journal-title":"Int Immunopharmacol"},{"key":"5898_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112063","author":"A Antoniou","year":"2023","unstructured":"Antoniou A et al (2023) Neuronal extracellular vesicles and associated microRNAs induce circuit connectivity downstream BDNF. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2023.112063","journal-title":"Cell Rep"},{"key":"5898_CR85","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ymthe.2019.11.017","volume":"28","author":"X Ge","year":"2020","unstructured":"Ge X et al (2020) Increased microglial exosomal miR-124-3p alleviates neurodegeneration and improves cognitive outcome after rmTBI. Mol Ther 28:503\u2013522","journal-title":"Mol Ther"},{"key":"5898_CR86","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345","journal-title":"Nat Biotechnol"},{"key":"5898_CR87","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/D4NA00501E","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS et al (2024) A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv 6:5803\u20135826","journal-title":"Nanoscale Adv"},{"key":"5898_CR88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D et al (2023) The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther 8:217","journal-title":"Signal Transduct Target Ther"},{"key":"5898_CR89","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41593-024-01743-y","volume":"27","author":"SJ Pfau","year":"2024","unstructured":"Pfau SJ et al (2024) Characteristics of blood\u2013brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells. Nat Neurosci 27:1892\u20131903","journal-title":"Nat Neurosci"},{"key":"5898_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0514-4","volume":"6","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Li C, Durisic N, Sullivan R, G\u00f6tz J (2018) Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons. Acta Neuropathol Commun 6:10","journal-title":"Acta Neuropathol Commun"},{"key":"5898_CR91","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","volume":"13","author":"G Morad","year":"2019","unstructured":"Morad G et al (2019) Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis. ACS Nano 13:13853\u201313865","journal-title":"ACS Nano"},{"key":"5898_CR92","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","volume":"9","author":"CC Chen","year":"2016","unstructured":"Chen CC et al (2016) Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol Bioeng 9:509\u2013529","journal-title":"Cell Mol Bioeng"},{"key":"5898_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03238-9","volume":"23","author":"M Zhao","year":"2025","unstructured":"Zhao M et al (2025) An anti-CD19-exosome delivery system navigates the blood\u2013brain barrier for targeting of central nervous system lymphoma. J Nanobiotechnol 23:173","journal-title":"J Nanobiotechnol"},{"key":"5898_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123403","volume":"322","author":"B Du","year":"2025","unstructured":"Du B et al (2025) Multi-targeted engineered hybrid exosomes as A\u03b2 nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer\u2019s disease. Biomaterials 322:123403","journal-title":"Biomaterials"},{"key":"5898_CR95","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12987-025-00680-7","volume":"22","author":"A \u0160pilak","year":"2025","unstructured":"\u0160pilak A et al (2025) Uptake of DU145 and LNCaP prostate cancer cell line derived extracellular vesicles is inversely correlated with blood\u2013brain barrier integrity in vitro. Fluids Barriers CNS 22:70","journal-title":"Fluids Barriers CNS"},{"key":"5898_CR96","doi-asserted-by":"crossref","unstructured":"Zhang S-S et al (2024) Immune cells: potential carriers or agents for drug delivery to the central nervous system. Mil Med Res 11:19","DOI":"10.1186\/s40779-024-00521-y"},{"key":"5898_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.011","volume":"142","author":"D Yuan","year":"2017","unstructured":"Yuan D et al (2017) Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials 142:1\u201312","journal-title":"Biomaterials"},{"key":"5898_CR98","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","volume":"11","author":"M Heidarzadeh","year":"2021","unstructured":"Heidarzadeh M et al (2021) Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls. Cell Biosci 11:142","journal-title":"Cell Biosci"},{"key":"5898_CR99","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7150\/thno.38198","volume":"10","author":"Z Wan","year":"2020","unstructured":"Wan Z et al (2020) Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics 10:218\u2013230","journal-title":"Theranostics"},{"key":"5898_CR100","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/pharmaceutics14061118","volume":"14","author":"H Choi","year":"2022","unstructured":"Choi H et al (2022) Quantitative biodistribution and pharmacokinetics study of GMP-grade exosomes labeled with 89Zr radioisotope in mice and rats. Pharmaceutics 14:1118","journal-title":"Pharmaceutics"},{"key":"5898_CR101","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10555-016-9630-4","volume":"35","author":"L Min","year":"2016","unstructured":"Min L, Shen J, Tu C, Hornicek F, Duan Z (2016) The roles and implications of exosomes in sarcoma. Cancer Metastasis Rev 35:377\u2013390","journal-title":"Cancer Metastasis Rev"},{"key":"5898_CR102","doi-asserted-by":"publisher","first-page":"2203361","DOI":"10.1002\/adhm.202203361","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J et al (2023) Bone-targeted exosomes: strategies and applications. Adv Healthc Mater 12:2203361","journal-title":"Adv Healthc Mater"},{"key":"5898_CR103","first-page":"171","volume":"50","author":"T Ma","year":"2025","unstructured":"Ma T et al (2025) Fused exosomal targeted therapy in periprosthetic osteolysis through regulation of bone metabolic homeostasis. Bioact Mater 50:171\u2013188","journal-title":"Bioact Mater"},{"key":"5898_CR104","doi-asserted-by":"publisher","first-page":"41729","DOI":"10.1021\/acsami.5c07676","volume":"17","author":"L Pei","year":"2025","unstructured":"Pei L et al (2025) Exosome-functionalized hydrogels improve cartilage repair by modulating BMSCs migration and differentiation. ACS Appl Mater Interfaces 17:41729\u201341746","journal-title":"ACS Appl Mater Interfaces"},{"key":"5898_CR105","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/bit.26045","volume":"114","author":"YI Wang","year":"2017","unstructured":"Wang YI, Abaci HE, Shuler ML (2017) Microfluidic blood\u2013brain barrier model provides in vivo\u2010like barrier properties for drug permeability screening. Biotechnol Bioeng 114:184\u2013194","journal-title":"Biotechnol Bioeng"},{"key":"5898_CR106","doi-asserted-by":"publisher","first-page":"2208966","DOI":"10.1002\/adma.202208966","volume":"35","author":"BJA Magoling","year":"2023","unstructured":"Magoling BJA et al (2023) Membrane protein modification modulates big and small extracellular vesicle biodistribution and tumorigenic potential in breast cancers in vivo. Adv Mater 35:2208966","journal-title":"Adv Mater"},{"key":"5898_CR107","doi-asserted-by":"publisher","first-page":"2001467","DOI":"10.1002\/advs.202001467","volume":"7","author":"AY-T Wu","year":"2020","unstructured":"Wu AY-T et al (2020) Multiresolution imaging using bioluminescence resonance energy transfer identifies distinct biodistribution profiles of extracellular vesicles and exomeres with redirected tropism. Adv Sci 7:2001467","journal-title":"Adv Sci"},{"key":"5898_CR108","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"H-X Chen","year":"2020","unstructured":"Chen H-X et al (2020) Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis 11:288","journal-title":"Cell Death Dis"},{"key":"5898_CR109","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1038\/s41467-021-26066-5","volume":"12","author":"I Pediaditakis","year":"2021","unstructured":"Pediaditakis I et al (2021) Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption. Nat Commun 12:5907","journal-title":"Nat Commun"},{"key":"5898_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12160","volume":"10","author":"K Feng","year":"2021","unstructured":"Feng K et al (2021) Reversing the surface charge of MSC-derived small extracellular vesicles by \u03b5PL-PEG-DSPE for enhanced osteoarthritis treatment. J Extracell Vesicles 10:e12160","journal-title":"J Extracell Vesicles"},{"key":"5898_CR111","doi-asserted-by":"crossref","unstructured":"Lee J et al (2023) Nanoparticles for lymph node-directed delivery. Pharmaceutics 15:565","DOI":"10.3390\/pharmaceutics15020565"},{"key":"5898_CR112","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1073\/pnas.1200718109","volume":"109","author":"JE Zuckerman","year":"2012","unstructured":"Zuckerman JE, Choi CHJ, Han H, Davis ME (2012) Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane. Proc Natl Acad Sci U S A 109:3137\u20133142","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5898_CR113","doi-asserted-by":"publisher","first-page":"1900111","DOI":"10.1002\/adtp.201900111","volume":"2","author":"DW Hwang","year":"2019","unstructured":"Hwang DW et al (2019) Chemical modulation of bioengineered exosomes for tissue-specific biodistribution. Adv Ther 2:1900111","journal-title":"Adv Ther"},{"key":"5898_CR114","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1039\/D2NA00290F","volume":"4","author":"V Palmieri","year":"2022","unstructured":"Palmieri V, Caracciolo G (2022) Tuning the immune system by nanoparticle\u2013biomolecular corona. Nanoscale Adv 4:3300\u20133308","journal-title":"Nanoscale Adv"},{"key":"5898_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00721","volume":"9","author":"E Karasu","year":"2018","unstructured":"Karasu E, Eisenhardt SU, Harant J, Huber-Lang M (2018) Extracellular vesicles: packages sent with complement. Front Immunol 9:721","journal-title":"Front Immunol"},{"key":"5898_CR116","first-page":"27","volume":"2","author":"T Chao","year":"2025","unstructured":"Chao T et al (2025) Exosome surface modification and functionalization: a narrative review of emerging technologies and their application potential in precision medicine. Adv Technol Neurosci 2:27\u201333","journal-title":"Adv Technol Neurosci"},{"key":"5898_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101656","volume":"32","author":"Z Han","year":"2025","unstructured":"Han Z et al (2025) Engineering exosome membrane disguised thermal responsive system for targeted drug delivery and controlled release across the blood-brain barrier. Mater Today Bio 32:101656","journal-title":"Mater Today Bio"},{"key":"5898_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120784","volume":"273","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomaterials 273:120784","journal-title":"Biomaterials"},{"key":"5898_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s40580-024-00426-5","volume":"11","author":"HK Choi","year":"2024","unstructured":"Choi HK, Chen M, Goldston LL, Lee K-B (2024) Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions. Nano Converg 11:19","journal-title":"Nano Converg"},{"key":"5898_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00086","volume":"8","author":"H Yu","year":"2020","unstructured":"Yu H et al (2020) Potential roles of exosomes in Parkinson\u2019s disease: from pathogenesis, diagnosis, and treatment to prognosis. Front Cell Dev Biol 8:86","journal-title":"Front Cell Dev Biol"},{"key":"5898_CR121","doi-asserted-by":"publisher","first-page":"17707","DOI":"10.1038\/s41598-023-44785-1","volume":"13","author":"J Haroon","year":"2023","unstructured":"Haroon J et al (2023) Use of transcranial low-intensity focused ultrasound for targeted delivery of stem cell-derived exosomes to the brain. Sci Rep 13:17707","journal-title":"Sci Rep"},{"key":"5898_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139724","volume":"296","author":"C Yang","year":"2025","unstructured":"Yang C et al (2025) Exosomes-encapsulated biomimetic polydopamine carbon dots with dual-targeting effect alleviate motor and non-motor symptoms of Parkinson\u2019s disease via anti-neuroinflammation. Int J Biol Macromol 296:139724","journal-title":"Int J Biol Macromol"},{"key":"5898_CR123","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7150\/thno.117143","volume":"16","author":"Q Huang","year":"2026","unstructured":"Huang Q et al (2026) Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation. Theranostics 16:545\u2013579","journal-title":"Theranostics"},{"key":"5898_CR124","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.7150\/thno.62330","volume":"11","author":"M Xu","year":"2021","unstructured":"Xu M et al (2021) Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics 11:8926\u20138944","journal-title":"Theranostics"},{"key":"5898_CR125","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/bc500291r","volume":"25","author":"T Smyth","year":"2014","unstructured":"Smyth T et al (2014) Surface functionalization of exosomes using click chemistry. Bioconjug Chem 25:1777\u20131784","journal-title":"Bioconjug Chem"},{"key":"5898_CR126","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1021\/acs.bioconjchem.0c00216","volume":"31","author":"S Song","year":"2020","unstructured":"Song S et al (2020) In situ one-step fluorescence labeling strategy of exosomes via bioorthogonal click chemistry for real-time exosome tracking in vitro and in vivo. Bioconjug Chem 31:1562\u20131574","journal-title":"Bioconjug Chem"},{"key":"5898_CR127","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian T et al (2018) Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials 150:137\u2013149","journal-title":"Biomaterials"},{"key":"5898_CR128","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","volume":"12","author":"M Mathieu","year":"2021","unstructured":"Mathieu M et al (2021) Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun 12:4389","journal-title":"Nat Commun"},{"key":"5898_CR129","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","volume":"299","author":"F Hosseini Shamili","year":"2019","unstructured":"Hosseini Shamili F et al (2019) Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release 299:149\u2013164","journal-title":"J Control Release"},{"key":"5898_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113690","volume":"155","author":"NF Hosseini","year":"2022","unstructured":"Hosseini NF et al (2022) AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomed Pharmacother 155:113690","journal-title":"Biomed Pharmacother"},{"key":"5898_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70018","volume":"13","author":"JH Sul","year":"2024","unstructured":"Sul JH et al (2024) Dopamine-conjugated extracellular vesicles induce autophagy in Parkinson\u2019s disease. J Extracell Vesicles 13:e70018","journal-title":"J Extracell Vesicles"},{"key":"5898_CR132","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2147\/IJN.S395246","volume":"18","author":"H Li","year":"2023","unstructured":"Li H et al (2023) Angiopep-2 modified exosomes load rifampicin with potential for treating central nervous system tuberculosis. Int J Nanomedicine 18:489\u2013503","journal-title":"Int J Nanomedicine"},{"key":"5898_CR133","doi-asserted-by":"publisher","first-page":"20240039","DOI":"10.1002\/EXP.20240039","volume":"5","author":"J Yang","year":"2025","unstructured":"Yang J et al (2025) Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma. Exploration 5:20240039","journal-title":"Exploration"},{"key":"5898_CR134","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","volume":"224","author":"SAA Kooijmans","year":"2016","unstructured":"Kooijmans SAA et al (2016) PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Controlled Release 224:77\u201385","journal-title":"J Controlled Release"},{"key":"5898_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01400-1","volume":"20","author":"G Zheng","year":"2022","unstructured":"Zheng G et al (2022) Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling. J Nanobiotechnol 20:220","journal-title":"J Nanobiotechnol"},{"key":"5898_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2021.100637","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J et al (2022) Efficient exosome extraction through the conjugation of superparamagnetic iron oxide nanoparticles for the targeted delivery in rat brain. Mater Today Chem 23:100637","journal-title":"Mater Today Chem"},{"key":"5898_CR137","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba3967","volume":"6","author":"L Liu","year":"2020","unstructured":"Liu L et al (2020) Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease. Sci Adv 6:eaba3967","journal-title":"Sci Adv"},{"key":"5898_CR138","doi-asserted-by":"publisher","DOI":"10.34133\/research.0402","volume":"7","author":"S Liu","year":"2024","unstructured":"Liu S et al (2024) Targeted delivery of engineered RVG-BDNF-exosomes: a novel neurobiological approach for ameliorating depression and regulating neurogenesis. Research 7:0402","journal-title":"Research"},{"key":"5898_CR139","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R et al (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun 9:1305","journal-title":"Nat Commun"},{"key":"5898_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202201406","volume":"34","author":"Q Wang","year":"2022","unstructured":"Wang Q et al (2022) Engineered exosomes with independent module\/cascading function for therapy of Parkinson\u2019s disease by multistep targeting and multistage intervention method. Adv Mater 34:2201406","journal-title":"Adv Mater"},{"key":"5898_CR141","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41416-023-02393-w","volume":"129","author":"Y Zhan","year":"2023","unstructured":"Zhan Y et al (2023) Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma. Br J Cancer 129:1083\u20131094","journal-title":"Br J Cancer"},{"key":"5898_CR142","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12951-020-00670-x","volume":"18","author":"X Li","year":"2020","unstructured":"Li X et al (2020) Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes. J Nanobiotechnology 18:113","journal-title":"J Nanobiotechnology"},{"key":"5898_CR143","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","volume":"18","author":"W Kong","year":"2024","unstructured":"Kong W et al (2024) Ultrasound-assisted CRISPRi-exosome for epigenetic modification of \u03b1-synuclein gene in a mouse model of Parkinson\u2019s disease. ACS Nano 18:7837\u20137851","journal-title":"ACS Nano"},{"key":"5898_CR144","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.01.001","volume":"31","author":"N Parada","year":"2021","unstructured":"Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F (2021) Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res 31:61\u201374","journal-title":"J Adv Res"},{"key":"5898_CR145","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.xphs.2017.02.030","volume":"106","author":"M Morishita","year":"2017","unstructured":"Morishita M, Takahashi Y, Nishikawa M, Takakura Y (2017) Pharmacokinetics of exosomes\u2014an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics. J Pharm Sci 106:2265\u20132269","journal-title":"J Pharm Sci"},{"key":"5898_CR146","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13346-013-0176-5","volume":"3","author":"JJF Verhoef","year":"2013","unstructured":"Verhoef JJF, Anchordoquy TJ (2013) Questioning the use of PEGylation for drug delivery. Drug Deliv Transl Res 3:499\u2013503","journal-title":"Drug Deliv Transl Res"},{"key":"5898_CR147","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","volume":"460","author":"T Ishida","year":"1999","unstructured":"Ishida T, Iden DL, Allen TM (1999) A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett 460:129\u2013133","journal-title":"FEBS Lett"},{"key":"5898_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121979","volume":"11","author":"F Susa","year":"2019","unstructured":"Susa F, Limongi T, Dumontel B, Vighetto V, Cauda V (2019) Engineered extracellular vesicles as a reliable tool in cancer nanomedicine. Cancers 11:1979","journal-title":"Cancers"},{"key":"5898_CR149","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.actbio.2012.01.035","volume":"8","author":"A Cimini","year":"2012","unstructured":"Cimini A et al (2012) Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of A\u03b2 aggregates modulate neuronal survival pathways. Acta Biomater 8:2056\u20132067","journal-title":"Acta Biomater"},{"key":"5898_CR150","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.biomaterials.2012.10.013","volume":"34","author":"M Malhotra","year":"2013","unstructured":"Malhotra M, Tomaro-Duchesneau C, Prakash S (2013) Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials 34:1270\u20131280","journal-title":"Biomaterials"},{"key":"5898_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102438","volume":"58","author":"Y Xu","year":"2024","unstructured":"Xu Y et al (2024) Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson\u2019s disease. Nano Today 58:102438","journal-title":"Nano Today"},{"key":"5898_CR152","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","volume":"112","author":"T Ishida","year":"2006","unstructured":"Ishida T et al (2006) Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 112:15\u201325","journal-title":"J Control Release"},{"key":"5898_CR153","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jconrel.2021.05.001","volume":"334","author":"SE Emam","year":"2021","unstructured":"Emam SE et al (2021) Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice. J Control Release 334:327\u2013334","journal-title":"J Control Release"},{"key":"5898_CR154","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jconrel.2023.08.010","volume":"361","author":"G Tr\u00e9ton","year":"2023","unstructured":"Tr\u00e9ton G et al (2023) Quantitative and functional characterisation of extracellular vesicles after passive loading with hydrophobic or cholesterol-tagged small molecules. J Control Release 361:694\u2013716","journal-title":"J Control Release"},{"key":"5898_CR155","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/srep21933","volume":"6","author":"YT Sato","year":"2016","unstructured":"Sato YT et al (2016) Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 6:21933","journal-title":"Sci Rep"},{"key":"5898_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl3406","volume":"10","author":"F Aliakbari","year":"2024","unstructured":"Aliakbari F et al (2024) The impact of hUC MSC\u2013derived exosome-nanoliposome hybrids on \u03b1-synuclein fibrillation and neurotoxicity. Sci Adv 10:eadl3406","journal-title":"Sci Adv"},{"key":"5898_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115635","volume":"24","author":"Z Osaid","year":"2023","unstructured":"Osaid Z et al (2023) Exosomes interactions with the blood\u2013brain barrier: implications for cerebral disorders and therapeutics. Int J Mol Sci 24:15635","journal-title":"Int J Mol Sci"},{"key":"5898_CR158","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12951-023-02259-6","volume":"22","author":"Z Chen","year":"2024","unstructured":"Chen Z et al (2024) Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnology 22:18","journal-title":"J Nanobiotechnology"},{"key":"5898_CR159","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41419-018-0816-2","volume":"9","author":"N Fussi","year":"2018","unstructured":"Fussi N et al (2018) Exosomal secretion of \u03b1-synuclein as protective mechanism after upstream blockage of macroautophagy. Cell Death Dis 9:757","journal-title":"Cell Death Dis"},{"key":"5898_CR160","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s12035-020-02243-3","volume":"58","author":"F Currim","year":"2021","unstructured":"Currim F et al (2021) Exosome release is modulated by the mitochondrial-lysosomal crosstalk in Parkinson\u2019s disease stress conditions. Mol Neurobiol 58:1819\u20131833","journal-title":"Mol Neurobiol"},{"key":"5898_CR161","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2421886122","volume":"122","author":"SD Palumbos","year":"2025","unstructured":"Palumbos SD, Popolow J, Goldsmith J, Holzbaur ELF (2025) Autophagic stress activates distinct compensatory secretory pathways in neurons. Proc Natl Acad Sci U S A 122:e2421886122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5898_CR162","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/aps.2017.178","volume":"39","author":"S Li","year":"2018","unstructured":"Li S, Lin Z, Jiang X, Yu X (2018) Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacol Sin 39:542\u2013551","journal-title":"Acta Pharmacol Sin"},{"key":"5898_CR163","doi-asserted-by":"publisher","first-page":"1254356","DOI":"10.3389\/fbioe.2023.1254356","volume":"11","author":"H Chen","year":"2023","unstructured":"Chen H et al (2023) Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics? Front Bioeng Biotechnol 11:1254356","journal-title":"Front Bioeng Biotechnol"},{"key":"5898_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103628","volume":"172","author":"D Ferreira","year":"2022","unstructured":"Ferreira D, Moreira JN, Rodrigues LR (2022) New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol Hematol 172:103628","journal-title":"Crit Rev Oncol Hematol"},{"key":"5898_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H et al (2021) Exosomes, a new star for targeted delivery. Front Cell Dev Biol 9:751079","journal-title":"Front Cell Dev Biol"},{"key":"5898_CR166","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jconrel.2017.10.020","volume":"268","author":"J Wang","year":"2017","unstructured":"Wang J et al (2017) Exosome is a mechanism of intercellular drug transfer: application of quantitative pharmacology. J. Controlled Release 268:147\u2013158","journal-title":"J Control Release"},{"key":"5898_CR167","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H et al (2023) Current strategies for exosome cargo loading and targeting delivery. Cells 12:1416","journal-title":"Cells"},{"key":"5898_CR168","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/life15020294","volume":"15","author":"M-C Chiang","year":"2025","unstructured":"Chiang M-C, Yang Y-P, Nicol CJB, Chiang T, Yen C (2025) Resveratrol-enhanced human neural stem cell-derived exosomes mitigate MPP+-induced neurotoxicity through activation of AMPK and Nrf2 pathways and inhibition of the NLRP3 inflammasome in SH-SY5Y cells. Life Basel 15:294","journal-title":"Life Basel"},{"key":"5898_CR169","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1039\/D0BM00427H","volume":"8","author":"Y Ye","year":"2020","unstructured":"Ye Y et al (2020) An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells. Biomater Sci 8:2966\u20132976","journal-title":"Biomater Sci"},{"key":"5898_CR170","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1039\/D0NR07622H","volume":"13","author":"L Duan","year":"2021","unstructured":"Duan L et al (2021) Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale 13:1387\u20131397","journal-title":"Nanoscale"},{"key":"5898_CR171","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J Zhou","year":"2017","unstructured":"Zhou J, Rossi J (2017) Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov 16:181\u2013202","journal-title":"Nat Rev Drug Discov"},{"key":"5898_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101478","volume":"298","author":"K Murakami","year":"2021","unstructured":"Murakami K, Izuo N, Bitan G (2021) Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases. J Biol Chem 298:101478","journal-title":"J Biol Chem"},{"key":"5898_CR173","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","volume":"17","author":"X Ren","year":"2019","unstructured":"Ren X et al (2019) Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model. Mol Ther Nucleic Acids 17:726\u2013740","journal-title":"Mol Ther Nucleic Acids"},{"key":"5898_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02634-x","volume":"22","author":"Z Iqbal","year":"2024","unstructured":"Iqbal Z et al (2024) Exosome for mRNA delivery: strategies and therapeutic applications. J Nanobiotechnology 22:395","journal-title":"J Nanobiotechnol"},{"key":"5898_CR175","doi-asserted-by":"publisher","first-page":"12363","DOI":"10.2147\/IJN.S542641","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L et al (2025) The application of exosomes from different sources loaded with natural small-molecule compounds in disease. Int J Nanomedicine 20:12363\u201312392","journal-title":"Int J Nanomedicine"},{"key":"5898_CR176","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine Nanotechnol Biol Med 12:655\u2013664","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"5898_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010038","volume":"14","author":"AJ Lenna\u00e1rd","year":"2022","unstructured":"Lenna\u00e1rd AJ, Mamand DR, Wiklander RJ, EL Andaloussi S, Wiklander OPB (2022) Optimised electroporation for loading of extracellular vesicles with doxorubicin. Pharmaceutics 14:38","journal-title":"Pharmaceutics"},{"key":"5898_CR178","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","volume":"27","author":"S Salarpour","year":"2019","unstructured":"Salarpour S et al (2019) Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci 27:533\u2013539","journal-title":"DARU J Pharm Sci"},{"key":"5898_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105218","volume":"148","author":"J Yang","year":"2021","unstructured":"Yang J et al (2021) Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson\u2019s disease. Neurobiol. Dis. 148:105218","journal-title":"Neurobiol Dis"},{"key":"5898_CR180","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12967-023-04461-4","volume":"21","author":"Y Geng","year":"2023","unstructured":"Geng Y et al (2023) FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson\u2019s disease via m6A-dependent regulation of ATM mRNA. J Transl Med 21:652","journal-title":"J Transl Med"},{"key":"5898_CR181","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"Zhuang X et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769\u20131779","journal-title":"Mol Ther"},{"key":"5898_CR182","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10561-022-10008-6","volume":"24","author":"M Mobahat","year":"2023","unstructured":"Mobahat M et al (2023) Curcumin-loaded human endometrial stem cells derived exosomes as an effective carrier to suppress alpha-synuclein aggregates in 6OHDA-induced Parkinson\u2019s disease mouse model. Cell Tissue Bank 24:75\u201391","journal-title":"Cell Tissue Bank"},{"key":"5898_CR183","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","volume":"205","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35\u201344","journal-title":"J Control Release"},{"key":"5898_CR184","unstructured":"ClinicalTrials.gov. Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease (NCT05152394).  https:\/\/clinicaltrials.gov\/study\/NCT05152394. Accessed 8 May 2026"},{"key":"5898_CR185","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","volume":"27","author":"M Izco","year":"2019","unstructured":"Izco M et al (2019) Systemic exosomal delivery of shRNA minicircles prevents Parkinsonian pathology. Mol Ther 27:2111\u20132122","journal-title":"Mol Ther"},{"key":"5898_CR186","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12987-025-00650-z","volume":"22","author":"H Kumabe","year":"2025","unstructured":"Kumabe H et al (2025) Proteome profile differences among human, monkey, and mouse brain microvessels and cultured brain microvascular endothelial cells. Fluids Barriers CNS 22:53","journal-title":"Fluids Barriers CNS"},{"key":"5898_CR187","unstructured":"Wasielewska JM et al (2020) Modeling the blood\u2013brain barrier to understand drug delivery in Alzheimer\u2019s disease. In: Huang X, editor. Alzheimer\u2019s Disease: Drug Discovery. Brisbane (AU): Exon Publications; Chapter 7"},{"key":"5898_CR188","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD et al (2018) Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133\u2013150","journal-title":"Nat Rev Neurol"},{"key":"5898_CR189","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/cells10092413","volume":"10","author":"ZA Nizamudeen","year":"2021","unstructured":"Nizamudeen ZA et al (2021) Low-power sonication can alter extracellular vesicle size and properties. Cells 10:2413","journal-title":"Cells"},{"key":"5898_CR190","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X et al (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38:754\u2013763","journal-title":"Acta Pharmacol Sin"},{"key":"5898_CR191","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans SAA et al (2013) Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Controlled Release 172:229\u2013238","journal-title":"J Controlled Release"},{"key":"5898_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121171","volume":"12","author":"NL Klyachko","year":"2020","unstructured":"Klyachko NL, Arzt CJ, Li SM, Gololobova OA, Batrakova EV (2020) Extracellular vesicle-based therapeutics: preclinical and clinical investigations. Pharmaceutics 12:1171","journal-title":"Pharmaceutics"},{"key":"5898_CR193","first-page":"500","volume":"25","author":"D Zheng","year":"2023","unstructured":"Zheng D et al (2023) Advances in extracellular vesicle functionalization strategies for tissue regeneration. Bioact Mater 25:500\u2013526","journal-title":"Bioact Mater"},{"key":"5898_CR194","unstructured":"European Parliament and Council. Directive 2001\/83\/EC, Annex I, Part IV: Advanced therapy medicinal products.  https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:02001L0083-20220101. Accessed 8 May 2026"},{"key":"5898_CR195","unstructured":"European Commission (2017) EudraLex\u2014Volume 4: Good manufacturing practice (GMP) Guidelines, Part IV: GMP requirements for advanced therapy medicinal products. Brussels: European Commission.  https:\/\/health.ec.europa.eu\/medicinal-products\/eudralex\/eudralex-volume-4_en. Accessed 8 May 2026"},{"key":"5898_CR196","unstructured":"European Medicines Agency (2008) Guideline on safety and efficacy follow-up\u2014risk management of advanced therapy medicinal products (EMEA\/149995\/2008). London: European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-safety-and-efficacy-follow-risk-management-advanced-therapy-medicinal-products_en.pdf. Accessed 8 May 2026"},{"key":"5898_CR197","unstructured":"U.S. Food and Drug Administration (2023) Warning Letter: Kimera Labs, Inc. (MARCS-CMS 649343). Silver Spring, MD: U.S. Food and drug administration.  https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/kimera-labs-inc-649343-09012023. Accessed 8 May 2026"},{"key":"5898_CR198","unstructured":"U.S. Food and Drug Administration. Important patient and consumer information about regenerative medicine therapies. Silver Spring, MD: U.S. Food and drug administration.  https:\/\/www.fda.gov\/vaccines-blood-biologics\/consumers-biologics\/important-patient-and-consumer-information-about-regenerative-medicine-therapies. Accessed 8 May 2026"},{"key":"5898_CR199","unstructured":"U.S. Food and Drug Administration (2020) Long term follow-up after administration of human gene therapy products: Guidance for industry. Silver spring, MD: U.S. Food and drug administration. https:\/\/www.fda.gov\/media\/113768\/download. Accessed 8 May 2026"},{"key":"5898_CR200","doi-asserted-by":"publisher","DOI":"10.1038\/s44386-025-00019-0","volume":"2","author":"M Michino","year":"2025","unstructured":"Michino M, Vendome J, Kufareva I (2025) AI meets physics in computational structure-based drug discovery for GPCRs. Npj Drug Discov 2:16","journal-title":"Npj Drug Discov"},{"key":"5898_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44385-024-00003-9","volume":"2","author":"Q Liao","year":"2025","unstructured":"Liao Q et al (2025) Application of artificial intelligence in drug-target interactions prediction: a review. Npj Biomed Innov 2:1","journal-title":"Npj Biomed Innov"},{"key":"5898_CR202","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/med.21764","volume":"41","author":"S Vatansever","year":"2021","unstructured":"Vatansever S et al (2021) Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions. Med Res Rev 41:1427\u20131473","journal-title":"Med Res Rev"},{"key":"5898_CR203","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2101005","volume":"21","author":"M Rock","year":"2022","unstructured":"Rock M et al (2022) Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques\u2014an in silico study. J. Integr. Neurosci. 21:5","journal-title":"J Integr Neurosci"},{"key":"5898_CR204","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41565-024-01725-y","volume":"19","author":"C Villa","year":"2024","unstructured":"Villa C et al (2024) Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle. Nat Nanotechnol 19:1532\u20131543","journal-title":"Nat Nanotechnol"},{"key":"5898_CR205","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c02364","author":"ML Hill","year":"2024","unstructured":"Hill ML et al (2024) Exosome-coated Prussian blue nanoparticles for specific targeting and treatment of glioblastoma. ACS Appl Mater Interfaces. https:\/\/doi.org\/10.1021\/acsami.4c02364","journal-title":"ACS Appl Mater Interfaces"},{"key":"5898_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12040372","volume":"12","author":"J Park","year":"2020","unstructured":"Park J, Lee H, Youn YS, Oh KT, Lee ES (2020) Tumor-homing pH-sensitive extracellular vesicles for targeting heterogeneous tumors. Pharmaceutics 12:372","journal-title":"Pharmaceutics"},{"key":"5898_CR207","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-023-39038-8","volume":"14","author":"A de Rus Jacquet","year":"2023","unstructured":"de Rus Jacquet A et al (2023) The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease. Nat Commun 14:3651","journal-title":"Nat Commun"},{"key":"5898_CR208","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acs.bioconjchem.1c00597","volume":"33","author":"AA Khan","year":"2022","unstructured":"Khan AA et al (2022) PET Imaging of small extracellular vesicles via [89Zr]Zr(oxinate)4 direct radiolabeling. Bioconjug Chem 33:473\u2013485","journal-title":"Bioconjug Chem"},{"key":"5898_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123014","volume":"356","author":"C-C Wang","year":"2024","unstructured":"Wang C-C et al (2024) Treatment of Parkinson\u2019s disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF. Life Sci 356:123014","journal-title":"Life Sci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05898-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05898-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05898-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:04:07Z","timestamp":1778655847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05898-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":209,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5898"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05898-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"626"}}